Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression

Tissue mechanics regulate development and homeostasis and are consistently modified in tumor progression. Nevertheless, the fundamental molecular mechanisms through which altered mechanics regulate tissue behavior and the clinical relevance of these changes remain unclear. We demonstrate that increased matrix stiffness modulates microRNA expression to drive tumor progression through integrin activation of β-catenin and MYC. Specifically, in human and mouse tissue, increased matrix stiffness induced miR-18a to reduce levels of the tumor suppressor phosphatase and tensin homolog (PTEN), both directly and indirectly by decreasing levels of homeobox A9 (HOXA9). Clinically, extracellular matrix stiffness correlated directly and significantly with miR-18a expression in human breast tumor biopsies. miR-18a expression was highest in basal-like breast cancers in which PTEN and HOXA9 levels were lowest, and high miR-18a expression predicted poor prognosis in patients with luminal breast cancers. Our findings identify a mechanically regulated microRNA circuit that can promote malignancy and suggest potential prognostic roles for HOXA9 and miR-18a levels in stratifying patients with luminal breast cancers.

[1]  R. Weinberg,et al.  Roles for microRNAs in the regulation of cell adhesion molecules , 2011, Journal of Cell Science.

[2]  Pier Paolo Pandolfi,et al.  Tenets of PTEN Tumor Suppression , 2008, Cell.

[3]  A. Nobel,et al.  Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D. Noh,et al.  Clinical application of shear wave elastography (SWE) in the diagnosis of benign and malignant breast diseases , 2011, Breast Cancer Research and Treatment.

[5]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[6]  M. R. Hough,et al.  The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice. , 2012, Blood.

[7]  William P Schiemann,et al.  TGF-β upregulates miR-181a expression to promote breast cancer metastasis. , 2013, The Journal of clinical investigation.

[8]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[9]  R. Sachidanandam,et al.  High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries , 2012, Nature Methods.

[10]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[11]  Patrick Delmas,et al.  Mechano-Gated Ion Channels in Sensory Systems , 2013, Cell.

[12]  Lana X Garmire,et al.  Whole-genome microRNA screening identifies let-7 and mir-18 as regulators of germ layer formation during early embryogenesis. , 2012, Genes & development.

[13]  William J. Gradishar,et al.  Response-Guided Neoadjuvant Chemotherapy for Breast Cancer , 2013 .

[14]  S. Elledge,et al.  A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Lakins,et al.  Exploring the link between human embryonic stem cell organization and fate using tension-calibrated extracellular matrix functionalized polyacrylamide gels. , 2012, Methods in molecular biology.

[16]  Genee Y. Lee,et al.  The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.

[17]  C. Larabell,et al.  Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Krasilnikov Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation. , 2000, Biochemistry. Biokhimiia.

[19]  L. Selleri,et al.  Hox cofactors in vertebrate development. , 2006, Developmental biology.

[20]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[21]  Lin He,et al.  mir‐17‐92: a polycistronic oncomir with pleiotropic functions , 2013, Immunological reviews.

[22]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[23]  Doron Betel,et al.  The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..

[24]  Sanjay Kumar,et al.  Mechanics, malignancy, and metastasis: The force journey of a tumor cell , 2009, Cancer and Metastasis Reviews.

[25]  Kandice R Johnson,et al.  Demystifying the effects of a three-dimensional microenvironment in tissue morphogenesis. , 2007, Methods in cell biology.

[26]  Scott A Gerber,et al.  Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis , 2008, Proceedings of the National Academy of Sciences.

[27]  Carme Camps,et al.  microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. , 2011, Cancer research.

[28]  M. Sheetz,et al.  Local force and geometry sensing regulate cell functions , 2006, Nature Reviews Molecular Cell Biology.

[29]  Tyson V. Sharp,et al.  LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing , 2010, Proceedings of the National Academy of Sciences.

[30]  Carlos Cuevas,et al.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.

[31]  Yufang Tang,et al.  PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner. , 2006, Cancer research.

[32]  Zhiguo Wang miRNA in the regulation of ion channel/transporter expression. , 2013, Comprehensive Physiology.

[33]  V. Weaver,et al.  Biomechanical regulation of cell orientation and fate , 2008, Oncogene.

[34]  R. Gelber,et al.  Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  Eva E. Rufino-Palomares,et al.  MicroRNAs as Oncogenes and Tumor Suppressors , 2013 .

[36]  MicroRNA modulate alveolar epithelial response to cyclic stretch , 2012, BMC Genomics.

[37]  M. Bani,et al.  Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics. , 2006, European journal of radiology.

[38]  Donald E Ingber,et al.  Cell tension, matrix mechanics, and cancer development. , 2005, Cancer cell.

[39]  Kevin W. Eliceiri,et al.  Matrix density-induced mechanoregulation of breast cell phenotype, signaling, and gene expression through a FAK-ERK linkage , 2009, Oncogene.

[40]  Cynthia A. Reinhart-King,et al.  Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.

[41]  A. Ganser,et al.  Lentivirus-mediated antagomir expression for specific inhibition of miRNA function , 2007, Nucleic acids research.

[42]  Anjali J. Koppal,et al.  Supplementary data: Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites , 2010 .

[43]  K. Irvine,et al.  Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins. , 2013, Developmental cell.

[44]  Kim Thomson,et al.  Quantitative shear wave ultrasound elastography: initial experience in solid breast masses , 2010, Breast Cancer Research.

[45]  E. Furth,et al.  Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster , 2006, Nature Genetics.

[46]  L. Gan,et al.  MicroRNA Profiling during Cardiomyocyte-Specific Differentiation of Murine Embryonic Stem Cells Based on Two Different miRNA Array Platforms , 2011, PloS one.

[47]  A. Schober,et al.  MicroRNAs in flow-dependent vascular remodelling. , 2013, Cardiovascular research.

[48]  Matthew J. Paszek,et al.  Scanning Angle Interference Microscopy Reveals Cell Dynamics at the Nano-scale , 2012, Nature Methods.

[49]  A. Tward,et al.  Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC , 2007, Nature Medicine.

[50]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[51]  Xiqiang Liu,et al.  Evaluating the microRNA targeting sites by luciferase reporter gene assay. , 2013, Methods in molecular biology.

[52]  Andrea Sottoriva,et al.  The shaping and functional consequences of the microRNA landscape in breast cancer , 2013, Nature.

[53]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[54]  P. Dennis,et al.  PTEN loss in the continuum of common cancers, rare syndromes and mouse models , 2011, Nature Reviews Cancer.

[55]  M. Benezra,et al.  HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. , 2010, The Journal of clinical investigation.

[56]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[57]  Woo Kyung Moon,et al.  Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer , 2013, European Radiology.